共 100 条
[1]
Allison DB(2001)Antipsychotic-induced weight gain: a review of the literature J Clin Psychiatry 62 22-31
[2]
Casey DE(2005)Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review CNS Drugs 19 193-865
[3]
Newcomer JW(2002)The effects of novel antipsychotics on glucose and lipid levels J Clin Psychiatry 63 856-212
[4]
Wirshing DA(2004)Atypical antipsychotics and glucose dysregulation: a systematic review Schizophr Res 71 195-17
[5]
Boyd JA(2004)The effects of antipsychotic therapy on serum lipids: a comprehensive review Schizophr Res 70 1-362
[6]
Meng LR(2015)“First do no harm.” A systematic review of the prevalence and management of antipsychotic adverse effects J Psychopharmacol 29 353-1260
[7]
Ballon JS(2006)Attenuation of antipsychotic induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: a randomized controlled trial J Clin Psychiatry 67 1253-194
[8]
Marder SR(2005)Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenia patients Int J Neuropsychopharmacol 8 183-1487
[9]
Wirshing WC(2006)Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states Prev Chronic Dis 3 A42-240
[10]
Jin H(2006)Mortality and medical comorbidity among patients with serious mental illness Psychiatr Serv 57 1482-1238